The Essentials
- What outpatient infusion is: Outpatient chemotherapy and immunotherapy mean receiving your prescribed cancer treatment or autoimmune diseases in a day care setting and going home the same day, rather than being admitted to a hospital ward. At IV One Infusion Center, Riyadh, outpatient infusion therapy has become the standard delivery model for most modern biologic, immunotherapy, targeted therapy, and supportive care regimens. This model is fully supported by Saudi Ministry of Health (MOH) licensing requirements and Council of Health Insurance (CHI) standards, enabling patients to receive specialized infusion treatments safely and efficiently in an ambulatory setting.
Why patients choose private over a large hospital: It is rarely about clinical quality; the protocols are the same. It is about predictable appointment times, private suites, family at your side, fewer waiting rooms and a calmer environment for a multi-hour treatment day.
What to expect on a treatment day: A typical session at a private infusion center runs 2 to 6 hours from check-in to discharge. Bloods, vitals and pharmacist review come first, then your nurse delivers your infusion in a private chair, followed by a short observation period and clear take-home guidance.
What Outpatient Chemotherapy and Immunotherapy Means
Outpatient chemotherapy and immunotherapy is the delivery of cancer treatment in a day care setting where you arrive for your appointment, receive your infusion under medical supervision, and go home the same day. There are no overnight stay and no hospital admission.
Almost every modern systemic cancer treatment is now suitable for outpatient delivery. According to the American Cancer Society, most chemotherapy and immunotherapy regimens worldwide are designed to be administered intravenously in outpatient or day care units rather than during a hospital admission. The World Health Organization actively encourages ambulatory cancer care in well-resourced settings because it improves patient experience without compromising safety.
Why Patients in Riyadh Are Choosing Private Outpatient Infusion
A growing number of patients in Riyadh are asking their oncologists whether they can receive their treatment outside the main hospital. The reasons are practical, not clinical.
1. Predictable appointment times
Large oncology day care units in Riyadh’s tertiary hospitals run at high capacity. Scheduled slots can drift by hours, and patients often wait in shared rooms with limited privacy. A dedicated outpatient center operates a tighter schedule with shorter dwell times, which matters when you are repeating a multi-hour appointment every 1 to 3 weeks.
2. Privacy and personal space
Hospital ward beds and shared infusion bays were not designed for treatments that you will receive repetitively over several months. Private and semi-private suites give you a calm, quiet environment to rest, read or simply be still.
3. Family at your side
Large hospitals often limit the number of visitors per patient. Private infusion centers are built to accommodate a partner, parent or close friend during your session, so you have someone you trust beside you throughout treatment.
4. Lower infection exposure
Cancer treatment suppresses your immune system. Spending less time in busy hospital corridors and shared waiting rooms reduces avoidable exposure to other infections, a concern reinforced repeatedly by the Oncology Nursing Society in their patient safety guidance.
5. One team that knows you
Scheduling, supportive care, vascular access coordination and cycle reporting are handled by one team that knows you by name, rather than passed between hospital departments. The same coordinator picks up your call from week one to your final cycle.
None of this replaces your oncologist. The decisions about your treatment plan remain with them. What changes is the experience of receiving that plan, week after week.
How a Treatment Day Works at IV one infusion Centre
The flow at a dedicated outpatient infusion center is designed to be calm and predictable. Here is what each part of a treatment day looks like.
Arrival and check in
You arrive at your scheduled time. Registration and identification take a few minutes, not an hour. You are taken straight to your private suite where your nurse meets you.
Pre infusion checks
Your nurse takes your vitals and asks how you have been feeling since your previous cycle. Bloods are drawn either on arrival or are completed in the day or two before, depending on your oncologist’s plan.
Pharmacist review and compounding
An oncology-trained pharmacist reviews your prescribed regimen and prepares your medication in a sterile compounding suite that complies with USP 800 and Saudi FDA standards. This is a non-negotiable safety step, and the reason patients should never accept infusion outside a properly licensed setting.
Vascular access
Your nurse accesses your port-a-Cath, PICC line or peripheral line, depending on your treatment plan. Each option has a clear purpose: ports and PICC lines protect your veins across long regimens, and peripheral lines are used for shorter or one-off infusions.
The infusion
Premedications come first to reduce the risk of reactions, then your main treatment. Your nurse stays close throughout, monitoring you continuously. You can read, sleep, work, talk to your family or simply rest.
Observation and discharge
After your infusion, you are observed for a short period, then discharged with written side-effect guidance, your supportive medications, and a confirmed date for the next cycle. We share a cycle summary with your treating oncologist the same day.
A typical session from arrival to discharge runs 2 to 6 hours, depending on the regimen. Same-day immunotherapy infusions can take 60 to 90 minutes, including check-in.
Large Hospital vs Private Infusion Centre in Riyadh
The clinical standards are the same. The drug, the dose and the protocol are set by your oncologist and do not change based on where you are treated. What changes is everything around the infusion itself.
| Experience Factor | Large Hospital Day Care | IV one infusion center |
| Setting | Shared infusion bay or ward bed | Private suite |
| Appointment timing | Variable, often delayed by hospital demand | Scheduled, with shorter dwell times |
| Check in to chair time | Often 60 to 120 minutes | Typically, 2 minutes |
| Family presence | Restricted, often one visitor only | Companions welcome throughout the session |
| Nurse to patient ratio | Higher, dictated by hospital volume | Lower, dedicated to fewer patients per shift, no exceed nurse/patient ratio (1:2) |
| Privacy | Limited, shared spaces | Designed around personal privacy |
| Infection exposure | Higher, busy hospital footfall | Lower, controlled access setting |
| Supportive care between cycles | Booked separately, often a separate visit | Scheduled alongside primary treatment |
| Clinical standards | Hospital grade | Hospital grade, MOH licensed and CHI accredited |
| Continuity with oncologist | Same hospital, internal handover | Direct working relationship with referring oncologist |
The trade-off is straightforward. If your treatment requires inpatient observation or you are clinically unstable, hospital-based care is the right setting. If your regime is suitable for outpatient delivery, a private infusion center gives you the same clinical safety with a meaningful upgrade in experience.
What Makes the IV One Outpatient Experience Different
IV One Infusion Center is Saudi Arabia’s first dedicated medical intravenous therapy center. We do not diagnose cancer or design treatment plans, that work belongs to your treating oncologist. What we do is administer the treatment your oncologist has prescribed, with hospital grade clinical standards and a setting built around your comfort. Meet our clinical team to see who delivers your care.
A faithful extension of your oncologist’s plan
We administer your prescribed regimen exactly as ordered. Every preparation is reviewed by an oncology trained pharmacist, and every infusion is delivered by a chemotherapy certified nurse.
A licensed and accredited center
IV One holds a Saudi Ministry of Health license (2024) and Council of Health Insurance accreditation (2024), with full Saudi FDA pharmacy oversight.
Private suites built for long sessions
Calm lighting, comfortable seating, refreshments, room for a family member or friend and small comforts that matter on a five-hour treatment day.
A single point of contact
You will know the name and number of your coordinator from your first call, and they will be the one who manages your scheduling and cycle coordination across treatment.
Supportive care integrated, not separate
Hydration, anti-nausea infusions, blood products and recovery drips can be scheduled around your treatment cycles on referral, cutting down repeat trips. Browse our full list of conditions we treat to see the wider scope of our infusion services.
A patient first culture
We know how much your time, your energy and your family mean during a treatment course. Everything in our center is designed around that.
How to Choose an Outpatient Infusion Centre in Riyadh
Not every facility offering intravenous therapy is equipped to administer chemotherapy and immunotherapy safely. Use this checklist before committing.
Licensing and accreditation
The center must hold an active Saudi MOH license and align with CBAHI and CHI standards. Ask to see proof if it is not displayed.
Oncology trained pharmacist on site
Every cytotoxic preparation should be reviewed and compounded by a pharmacist trained in oncology, in a sterile USP 800-compliant suite.
Chemotherapy certified nursing staff
Ask whether nurses are certified in chemotherapy administration and whether there is a documented competency assessment. Generalist IV training is not enough.
Defined emergency protocols
The center must have a clear, rehearsed protocol for hypersensitivity reactions, extravasation and other emergencies, with onsite resuscitation capacity and a transfer pathway to a tertiary hospital.
Continuity with your treating oncologist
The center should work with your oncologist, share cycle reports the same day and never make independent changes to your prescribed plan.
Patient experience
Visit before you commit. A treatment day will repeat many times. The space, the team and the small details matter.
Frequently Asked Questions
Is outpatient chemotherapy safe?
Is immunotherapy delivered as outpatient care?
Will I need a referral from my oncologist?
Can my family stay with me during treatment?
How long does a session take?
How do you coordinate with my hospital oncologist?
What happens if I have a reaction during treatment?
What other conditions do IV One treat?
Key Takeaways
Outpatient chemotherapy and immunotherapy is the default delivery model for most modern cancer treatment in Riyadh, fully supported by Saudi MOH licensed and CHI accredited providers.
The clinical standards between a large hospital day care and a properly accredited private infusion center are the same. The difference is in privacy, scheduling, family presence and the calm of the environment.
A treatment day at a private infusion center runs 2 to 6 hours from check in to discharge, with a single team handling scheduling, supportive care and coordination with your oncologist.
Choosing a center should always start with licensing, oncology pharmacist oversight, certified nursing, emergency capability and continuity with your treating oncologist.
IV One Infusion Center is Saudi Arabia’s first dedicated medical IV therapy center, MOH licensed and CHI accredited, and administers oncology infusion therapy on referral from your treating oncologist.
Speak to IV One
If you have a treatment plan from your oncologist and you would like to explore administering it as outpatient care in Riyadh, our team is here to help. We will coordinate directly with your oncologist, walk you through what your treatment days will look like, and book your first session at a time that works for you and your family.
Get in touch with the IV One team to start the conversation.
Sources and references: American Cancer Society, American Society of Clinical Oncology (ASCO), National Comprehensive Cancer Network (NCCN), European Society for Medical Oncology (ESMO), World Health Organisation (WHO), Saudi Food and Drug Authority (SFDA), Saudi Ministry of Health (MOH), Saudi Central Board for Accreditation of Healthcare Institutions (CBAHI), Council of Health Insurance (CHI), Oncology Nursing Society (ONS).
Dr. Hamad ALAssaf
MD — Internal Medicine / Hematologist, IV One Health Centre